Distinguished Speaker Series
December 4, 2015
Distinguished Speaker Series: The role of physical activity in the primary and secondary prevention of cancer
Presented by Siobhan Phillips, PhD
Director: David X. Marquez, PhD
The EPL attempts to study and ultimately reduce health disparities. They particularly focus on different populations that are affected, including racial and ethnic minorities, residents of rural areas, women, children, the elderly, and persons with disabilities.
The Integrative Physiology Laboratory’s (IPL) faculty research focuses on health-related research across several disciplines using translational approaches that are both cellular and whole-body in scope. The current faculty’s research integrates aspects of cardiovascular function, metabolism, inflammation, hydration and nutrition status and exercise/physical activity, in healthy individuals and in populations at risk or who suffer from chronic disease, such as hypertension, type 2 diabetes, kidney disease, obesity, etc. The IPL utilizes state-of-the-art applied and basic techniques to accomplish its research goals. (Website currently under construction.)
Director: Carol Braunschweig, PhD
The Laboratory of Human Nutrition and Obesity has research focused in three major areas: the assessment of how nutritional intake and non-volitional nutritional support (parenteral and enteral feedings) impact overall risks and clinical outcomes in hospitalized patients, the impact of obesity and body composition on disease risks in various populations including women, the disabled and minority populations, and the design, implementation and assessment of exercise and nutrition interventions for obesity prevention and treatment.
Directors: Mark D. Grabiner, PhD, Karen L. Troy, PhD
Dedicated to the study of the influence of aging processes on locomotion, and how these influences conspire to increase the incidence of fall-related injury. The goal of the laboratory's work is to reduce the incidence of falls by older adults.
Director: Michael Brown, PhD
The VHL focuses on elucidating the mechanisms by which changes in lifestyle factors lead to beneficial changes in both conventional and nonconventional cardiovascular disease risk factors. It focuses primarily, but not exclusively, on African Americans as their morbidity and mortality rates from cardiovascular disease, particularly hypertension, exceed other US populations. A combination of cell/molecular biology, human intervention, and community involvement uniquely positions us the VHL a translational research group in vascular health.